TrialBritish journal of cancer2019

Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2 + metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16).

Sung Hoon Sim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.